Management of UTI with Obstructive Ureteric Calculus
This patient requires urgent urinary tract decompression via either percutaneous nephrostomy or retrograde ureteral stent placement, combined with immediate empirical intravenous antibiotics, followed by definitive stone treatment once the infection has resolved. 1
Immediate Management: Urgent Decompression
Urgent decompression of the obstructed system is mandatory and should be performed immediately to prevent progression to urosepsis and preserve renal function. 1
Choice of Decompression Method
Both percutaneous nephrostomy and retrograde ureteral stenting are acceptable options, with no clear superiority of one method over the other in terms of infection resolution or complication rates. 2
Percutaneous nephrostomy is preferred when: 3
- The patient is critically ill or hemodynamically unstable
- High-grade hydronephrosis is present
- Retrograde stent placement fails or is technically difficult
- Large stones (>10 mm) are present
Retrograde ureteral stent placement is appropriate when: 3
- The patient is stable enough to tolerate cystoscopy
- Stones are smaller (≤10 mm)
- Low-grade hydronephrosis is present
Antibiotic Management
Initial Empirical Therapy
Start broad-spectrum intravenous antibiotics immediately, before decompression if possible. 1
The 2024 EAU guidelines recommend the following empirical regimens for complicated UTI with systemic symptoms: 1
- Amoxicillin plus an aminoglycoside, OR
- Second-generation cephalosporin plus an aminoglycoside, OR
- Intravenous third-generation cephalosporin
Collect urine for culture and susceptibility testing before and after decompression, then adjust antibiotics based on antibiogram results. 1
Duration of Antibiotic Therapy
Treat with antibiotics for 7-14 days total, with duration closely related to resolution of the underlying obstruction. 1
- Once hemodynamically stable and afebrile for at least 48 hours, consider shortening to 7 days if there are relative contraindications to prolonged antibiotic use. 1
- Research shows that prolonged antibiotic courses beyond what is needed for clinical resolution do not reduce postoperative infection rates and may contribute to antibiotic resistance. 4
Timing of Definitive Stone Treatment
Delay definitive stone removal until the infection has completely resolved. 1
Optimal Timing Window
Perform ureteroscopic lithotripsy or other definitive stone treatment approximately 7-21 days after initial decompression and infection control. 5, 6
- Effective drainage clearly abates infection after stenting for 7 days, with significant decreases in WBC count and positive urine cultures. 5
- Ureteral stent placement periods exceeding 21 days are associated with increased risk of postoperative febrile UTI (independent risk factor on multivariate analysis). 6
- The time between decompression and stone treatment does not impact postoperative urosepsis rates when infection is adequately controlled, but prolonged stenting increases complications. 4, 6
Definitive Stone Treatment Options
Once infection has resolved, choose stone removal method based on stone characteristics: 3
- Ureteroscopic lithotripsy for ureteral stones and smaller renal stones
- Percutaneous nephrolithotomy (PCNL) for larger renal stones (>10 mm)
- Extracorporeal shock wave lithotripsy (ESWL) for select cases with smaller stones
Administer perioperative antibiotic prophylaxis for all endourological procedures. 1
Critical Pitfalls to Avoid
Do not use fluoroquinolones empirically if: 1
- Local resistance rates exceed 10%
- The patient is from a urology department
- The patient has used fluoroquinolones in the last 6 months
Monitor for progression to sepsis using qSOFA criteria: respiratory rate ≥22/min, altered mental status, or systolic blood pressure ≤100 mmHg. 1 If sepsis develops, intensive care may be necessary.
Avoid prolonged antibiotic courses without clear indication, as this does not prevent postoperative infections and promotes resistance. 4
Ensure operation time remains under 75 minutes during ureteroscopy, as longer operative times independently increase febrile UTI risk. 6